<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00547989</url>
  </required_header>
  <id_info>
    <org_study_id>MEC 05-105.5</org_study_id>
    <nct_id>NCT00547989</nct_id>
  </id_info>
  <brief_title>Paravertebral Block, an Adjunct to General Anaesthesia for Breast Surgery?</brief_title>
  <official_title>Paravertebral Block, an Adjunct to General Anaesthesia for Breast Surgery?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim is to study if a paravertebral block as an adjunct to general anesthesia is a suitable
      technique for extended, one sided, breast surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Usually breast tumour surgery in the Academic Hospital Maastricht is performed under general
      anaesthesia. Perioperative pain management consists of paracetamol and naproxen
      preoperatively, opioids during surgery and local wound infiltration at the end of surgery
      with 10cc Bupivacaine 0.25%. Postoperative pain management consists of paracetamol,
      occasionally combined with Naproxen, and if necessary Piritramide 0.2 mg/kg i.m.

      Alternatively there is the possibility to perform breast surgery under a thoracic
      paravertebral block (PVB) with or without general anesthesia.

      A PVB according to Eason and Wyatt (1) can be performed preoperatively with insertion of an
      end-hole catheter T3-T4. With this technique we expect a better pain relief postoperatively.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2006</start_date>
  <completion_date type="Actual">May 2011</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>reduction of unplanned admissions and reduction of VAS score.</measure>
    <time_frame>one week</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>to determine the safety and performance (efficacy) of the technique and the investigational product.</measure>
    <time_frame>one week</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">46</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>control</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PVB with ropivacaine and postoperative pump 5ml/h</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PVB with ropivacaine, 10 patients included but not analysed</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>standard anaesthesia (bupivacaine)</intervention_name>
    <description>Local infiltration with bupivacaine and Piritramide and Paracetamol as postoperative analgesic, and ondansetron as required</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>additional pvb (ropivacaine) and elastomeric disposable infusion pump</intervention_name>
    <description>Patients in group 2 will receive PVB with ropivacaine and postoperative pump 5ml/h.</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>additional pvb (ropivacaine)</intervention_name>
    <description>Patients in group 1 will receive PVB with ropivacaine</description>
    <arm_group_label>Experimental 1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Extended mamma surgery one-sided

          -  ASA class I and II

        Exclusion Criteria:

          -  All contra indications for local anaesthesia

          -  Coagulation disorders

          -  Infection

          -  Allergic reactions
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Esther Bouman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>azM</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Maastricht</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 18, 2007</study_first_submitted>
  <study_first_submitted_qc>October 22, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 23, 2007</study_first_posted>
  <last_update_submitted>June 10, 2014</last_update_submitted>
  <last_update_submitted_qc>June 10, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 11, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ASA class I and II</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

